Approvals/HSA/Bendamustine Hydrochloride ADVAGEN Powder for Concentrate for Solution for Infusion 25 mg/vial

Approved

THERAPEUTIC

Bendamustine Hydrochloride ADVAGEN Powder for Concentrate for Solution for Infusion 25 mg/vial

Sichuan Huiyu Pharmaceutical Co., Ltd. (CHINA)🇸🇬 Health Sciences Authority

Approval Id: c1e602baf87a9ba2
Drug Name: Bendamustine Hydrochloride ADVAGEN Powder for Concentrate for Solution for Infusion 25 mg/vial
Product Name: Bendamustine Hydrochloride ADVAGEN Powder for Concentrate for Solution for Infusion 25 mg/vial
Approval Number: SIN17502P
Approval Date: 2026-03-26
Registrant: ADVAGEN PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: Prescription Only
Dosage Form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route Of Administration: INTRAVENOUS

Approved

Agency

HSA

Country

🇸🇬

Approval Date

Mar 26, 2026

Approval ID

c1e602baf87a9ba2

Type

Therapeutic